Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nippon Shinyaku
Welcome,
Profile
Billing
Logout
23 Products
124 Diseases
23 Products
327 Trials
12149 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
35
70
105
140
175
210
245
280
315
350
Gazyva
(obinutuzumab) / Roche, Biogen
Vyxeos
(cytarabine/daunorubicin liposomal formulation) / Jazz
Opsumit
(macitentan) / Nippon Shinyaku, J&J
Emcyt
(estramustine) / Pfizer, Nippon Shinyaku
Jaypirca
(pirtobrutinib) / Eli Lilly
Uptravi
(selexipag) / J&J
Fintepla
(low-dose fenfluramine) / UCB
Campral EC
(acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Elzonris
(tagraxofusp-erzs) / Menarini
Amnolake
(tamibarotene) / Rege Nephro
buloxibutid
(C21) / Vicore Pharma
deramiocel
(CAP-1002) / Capricor, Lonza, Nippon Shinyaku
Viltepso
(viltolarsen) / Nippon Shinyaku, National Center of Neurology and Psychiatry
radgocitabine
(DFP-10917) / Delta-Fly Pharma
Uptravi Injection
(selexipag IV) / J&J, Nippon Shinyaku
brogidirsen
(NS-089/NCNP-02) / Nippon Shinyaku, National Center of Neurology and Psychiatry
clemidsogene lanparvovec
(RGX-121) / REGENXBIO, Nippon Shinyaku
ilginatinib
(NS-018) / Nippon Shinyaku
RGX-111
/ REGENXBIO, Nippon Shinyaku
NS-229
/ Nippon Shinyaku
NS-580
/ Nippon Shinyaku
afacifenacin fumarate
(SMP-986) / Sumitomo Pharma, Nippon Shinyaku
